Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L22, mitochondrial (MRPL22) is a structural protein component of the large 39S subunit of the mitochondrial ribosome in humans, encoded by the nuclear gene MRPL22[1][2][6]. It is essential for protein synthesis within mitochondria, functioning in mitochondrial translation[1][2][3]. Mammalian mitochondrial ribosomal proteins, including MRPL22, differ significantly in sequence among species and are largely responsible for assembling proteins encoded by mitochondrial DNA. MRPL22 does not serve as a therapeutic target, and no specific disease associations, interacting drugs, or biomarker roles are documented in current databases[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L22, mitochondrial (MRPL22).